Finally, in light of the clinical application of Emilin2 for the treatment of bone fracture, recombinant Emilin2 was introduced to the injury site using a collagen carrier, at the same time as macrophage depletion in the bone-surrounding tissue (Fig. 5a and Additional file 5: Fig. S5a, b). Here, EMILIN2 is linked to bone fracture.